NEWS
Announcing a $200M VHH discovery collaboration with Abkyu to accelerate next-gen biologics.
Jeevan Therapeutics has entered into a strategic discovery partnership with Abkyu to accelerate the development of next-generation biologics aimed at transforming patient care.
Newsletters
Breaking New Ground: Jeevan's Recent Wins and What's Ahead
In the first part of 2025 we have achieved several key milestones positioning Jeevan for an exciting rest of year, looking into 2026!